miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Junguk Hur und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58202, USA. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, MicroRNAs, Neurodegenerative Diseases, Frontotemporal Dementia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, ATSDR CDC HHS, NIEHS NIH HHS.
Abstract (Originalsprache)
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease. Its complex pathogenesis and phenotypic heterogeneity hinder therapeutic development and early diagnosis. Altered RNA metabolism is a recurrent pathophysiologic theme, including distinct microRNA (miRNA) profiles in ALS tissues. We profiled miRNAs in accessible biosamples, including skin fibroblasts and whole blood and compared them in age- and sex-matched healthy controls versus ALS participants with and without repeat expansions to chromosome 9 open reading frame 72 (C9orf72; C9-ALS and nonC9-ALS), the most frequent ALS mutation. We identified unique and shared profiles of differential miRNA (DmiRNA) levels in each C9-ALS and nonC9-ALS tissues versus controls. Fibroblast DmiRNAs were validated by quantitative real-time PCR and their target mRNAs by 5-bromouridine and 5-bromouridine-chase sequencing. We also performed pathway analysis to infer biological meaning, revealing anticipated, tissue-specific pathways and pathways previously linked to ALS, as well as novel pathways that could inform future research directions. Overall, we report a comprehensive study of a miRNA profile dataset from C9-ALS and nonC9-ALS participants across two accessible biosamples, providing evidence of dysregulated miRNAs in ALS and possible targets of interest. Distinct miRNA patterns in accessible tissues may also be leveraged to distinguish ALS participants from healthy controls for earlier diagnosis. Future directions may look at potential correlations of miRNA profiles with clinical parameters.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND 58202, USA.
- Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
- NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Chemical Engineering, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, MI 48109, USA.
Förderung
- NIH HHS
- ATSDR CDC HHS
- NIEHS NIH HHS
- NINDS NIH HHS
- NCATS NIH HHS
- ACL HHS
- University of Michigan
- NIH
Zitieren
APA
Hur, J., Paez-Colasante, X., Figueroa-Romero, C., Lo, T. W., Barmada, S. J., Paulsen, M. T., Ljungman, M., Alakwaa, F. M., Savelieff, M. G., Goutman, S. A., & Feldman, E. L. (2023). miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac250
Vancouver
Hur J, Paez-Colasante X, Figueroa-Romero C, Lo TW, Barmada SJ, Paulsen MT, et al. miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac250
BibTeX
@article{Hur2023,
author = {Hur, Junguk and Paez-Colasante, Ximena and Figueroa-Romero, Claudia and Lo, Ting-Wen and Barmada, Sami J and Paulsen, Michelle T and Ljungman, Mats and Alakwaa, Fadhl M and Savelieff, Masha G and Goutman, Stephen A and Feldman, Eva L},
title = {miRNA analysis reveals novel dysregulated pathways in amyotrophic lateral sclerosis},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac250}
}
EUVIMED